Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30

$12.95−0.45 (-3.36%)

Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –

Pharming profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was 0.8%, against -4.0% the year before.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	0.8%	+4.7
FY2024	Dec 31, 2024	-4.0%	+0.3
FY2023	Dec 31, 2023	-4.3%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PHAR.

Revenue growth26.6% · median 38.4%

Gross margin87.9% · median 87.4%

Operating margin6.9% · median -63.0%

Net margin0.8% · median -44.9%

Advertisement
300 × 250

See a number that looks wrong?